Skip to content

Biohaven BHVN Total Assets

Total Assets at other companies

Eli Lilly logo
Eli LillyLLY
$116.58B+30.4%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$1.39B+86.6%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$497.6M+64.7%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$1.03B-21.6%
uniQure logo
uniQureQURE
$778.71M+28.6%
Roivant Sciences logo
Roivant SciencesROIV
$5.71B+5.0%

Other financials

Income statement

See full
Operating income-$130.4M+41.1%
Net income-$130.5M+41.1%
EPS (diluted)-$0.88+59.4%

Balance sheet

See full
Cash & equivalents$277.1M+170%
Total debt$286.2M+706%
Total equity$129.5M-50.1%

Cash flow

See full
Operating cash flow-$149.9M+9.2%
CapEx--100%
Free cash flow-$149.9M+9.5%

Valuation

See full
Market cap$2.23B-48.1%
Enterprise value$2.23B-46.3%

Returns & leverage

See full
Return on equity-333%+17.9pp
Debt / equity2.2×+2.1×
Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biohaven's total assets?
Biohaven (BHVN) reported total assets of $466.41M in Q1 2026.
How has Biohaven's total assets changed year-over-year?
Biohaven's total assets increased by 1.6% year-over-year, from $458.95M to $466.41M.
What is the long-term trend for Biohaven's total assets?
Over 4 years (2021 to 2025), Biohaven's total assets has grown at a 33.5% compound annual growth rate (CAGR), from $142.06M to $451.45M.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.